Meningococcal interaction to microvasculature triggers the tissular lesions of purpura fulminans

Journal of Infectious Diseases

Volumn 208, Issue 10, 2013, Pages 1590-1597

  Join Lambert, Olivier ^a,b,c   Lecuyer, Hervé ^a,b,c   Miller, Florence ^a,b   Lelievre, Lucie ^a,b,c   Jamet, Anne ^a,b,c   Furio, Laetitia ^a,b   Schmitt, Alain ^b,f,g   Pelissier, Philippe ^e   Fraitag, Sylvie ^b,d   Coureuil, Mathieu ^a,b   Nassif, Xavier ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Laboratoire de Microbiologie   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e SAINT JOSEPH HOSPITAL   (France)

^f INSTITUT COCHIN   (France)

^g CNRS   (France)

Author keywords

Endothelial cells; Infectious diseases; Neisseria meningitidis; Purpura fulminans; Scid mice; Vascular infection; Xenograft model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; FEMALE; FULMINATING PURPURA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MENINGOCOCCEMIA; MICROVASCULATURE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; THROMBOSIS; ULTRASTRUCTURE; VASCULAR DISEASE; VASCULAR LEAKAGE; VASCULITIS;

ENDOTHELIAL CELLS; INFECTIOUS DISEASES; NEISSERIA MENINGITIDIS; PURPURA FULMINANS; SCID MICE; VASCULAR INFECTION; XENOGRAFT MODEL;

ANIMALS; BACTERIAL ADHESION; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FIMBRIAE, BACTERIAL; HETEROGRAFTS; HUMANS; MENINGOCOCCAL INFECTIONS; MICE; MICROVESSELS; NEISSERIA MENINGITIDIS; PURPURA FULMINANS; SKIN; SKIN TRANSPLANTATION;

EID: 84888630325     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit301     Document Type: Article

References (42)

1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369:2196-210.
2. Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. Methods Mol Biol 2012; 799:21-35.
3. Baselga E, Drolet BA, Esterly NB. Purpura in infants and children. J Am Acad Dermatol 1997; 37:673-705; quiz 6-7.
4. Marzouk O, Thomson AP, Sills JA, Hart CA, Harris F. Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child 1991; 66:485-7.
5. Baxter P, Priestley B. Meningococcal rash. Lancet 1988; 1:1166-7.
6. Ramesh V, Mukherjee A, Chandra M, et al. Clinical, histopathologic & immunologic features of cutaneous lesions in acute meningococcaemia. Indian J Med Res 1990; 91:27-32.
7. van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13:144-66, table of contents.
8. DeVoe IW. The meningococcus and mechanisms of pathogenicity. Microbiol Rev 1982; 46:162-90.
9. Pron B, Taha MK, Rambaud C, et al. Interaction of Neisseria meningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC. J Infect Dis 1997; 176:1285-92.
10. Sotto MN, Langer B, Hoshino-Shimizu S, de Brito T. sPathogenesis of cutaneous lesions in acute meningococcemia in humans: light, immunofluorescent, and electron microscopic studies of skin biopsy specimen. J Infect Dis 1976; 133:506-14.
11. Dupin N, Lecuyer H, Carlotti A, et al. Chronic meningococcemia cutaneous lesions involve meningococcal perivascular invasion through the remodeling of endothelial barriers. Clin Infect Dis 2012; 54:1162-5.
12. Harrison OB, Robertson BD, Faust SN, et al. Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo. Infect Immun 2002; 70:5193-201.
13. Hill WR, Kinney TD. The cutaneous lesions in acute meningococcemia; a clinical and pathologic study. JAMA 1947; 134:513-8.
14. Mairey E, Genovesio A, Donnadieu E, et al. Cerebral microcirculation shear stress levels determine Neisseria meningitidis attachment sites along the blood-brain barrier. J Exp Med 2006; 203:1939-50.
15. Hansen JK, Forest KT. Type IV pilin structures: insights on shared architecture, fiber assembly, receptor binding and type II secretion. J Mol Microbiol Biotechnol 2006; 11:192-207.
16. Lecuyer H, Nassif X, Coureuil M. Two strikingly different signaling pathways are induced by meningococcal type IV pili on endothelial and epithelial cells. Infect Immun 2012; 80:175-86.
17. Eugene E, Hoffmann I, Pujol C, Couraud PO, Bourdoulous S, Nassif X. Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells. J Cell Sci 2002; 115:1231-41.
18. Merz AJ, Enns CA, So M. Type IV pili of pathogenic Neisseriae elicit cortical plaque formation in epithelial cells. Mol Microbiol 1999; 32:1316-32.
19. Nassif X, Mathison JC, Wolfson E, Koziol JA, Ulevitch RJ, So M. Tumour necrosis factor alpha antibody protects against lethal meningococcaemia. Mol Microbiol 1992; 6:591-7.
20. Vu DM, Shaughnessy J, Lewis LA, Ram S, Rice PA, Granoff DM. Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect Immun 2012; 80:643-50.
21. Holbein BE, Jericho KW, Likes GC. Neisseria meningitidis infection in mice: influence of iron, variations in virulence among strains, and pathology. Infect Immun 1979; 24:545-51.
22. Yan HC, Juhasz I, Pilewski J, Murphy GF, Herlyn M, Albelda SM. Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest 1993; 91:986-96.
23. Nassif X, Lowy J, Stenberg P, O'Gaora P, Ganji A, So M. Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells. Mol Microbiol 1993; 8:719-25.
24. Barrandon Y, Li V, Green H. New techniques for the grafting of cultured human epidermal cells onto athymic animals. J Invest Dermatol 1988; 91:315-8.
25. Calver GA, Kenny CP, Kushner DJ. Inhibition of the growth of Neisseria meningitidis by reduced ferritin and other iron-binding agents. Infect Immun 1979; 25:880-90.
26. Simonson C, Brener D, DeVoe IW. Expression of a high-affinity mechanism for acquisition of transferrin iron by Neisseria meningitidis. Infect Immun 1982; 36:107-13.
27. Holbein BE. Iron-controlled infection with Neisseria meningitidis in mice. Infect Immun 1980; 29:886-91.
28. Holbein BE. Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin. Infect Immun 1981; 34:120-5.
29. Hackett SJ, Thomson AP, Hart CA. Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 2001; 50:847-59.
30. Ovstebo R, Brandtzaeg P, Brusletto B, et al. Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004; 42:2980-7.
31. Evans RW, Glick B, Kimball F, Bobell M. Fatal intravascular consumption coagulopathy in meningococcal sepsis. Am J Med 1969; 46:910-8.
32. Virji M, Kayhty H, Ferguson DJ, Alexandrescu C, Heckels JE, Moxon ER. The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol Microbiol 1991; 5:1831-41.
33. Nassif X, Marceau M, Pujol C, Pron B, Beretti JL, Taha MK. Type-4 pili and meningococcal adhesiveness. Gene 1997; 192:149-53.
34. Virji M, Alexandrescu C, Ferguson DJ, Saunders JR, Moxon ER. Variations in the expression of pili: The effect on adherence of Neisseria meningitidis to human epithelial and endothelial cells. Mol Microbiol 1992; 6:1271-9.
35. Black-Schaffer B, Hiebert TG, Kerby GP. Experimental study of purpuric meningococcemia in relation to the Shwartzmann phenomenon; with discussion of meningococcic purpura, the Waterhouse-Friderichsen syndrome and bilateral renal cortical necrosis. Arch Pathol 1947; 43:28-54.
36. Stetson CA, Good RA. Studies on the mechanism of the Shwartzmanphenomenon; evidence for the participation of polymorphonuclear leucocytes in the phenomenon. J Exp Med 1951; 93:49-63.
37. Doulet N, Donnadieu E, Laran-Chich MP, et al. Neisseria meningitidis infection of human endothelial cells interferes with leukocyte transmigration by preventing the formation of endothelial docking structures. J Cell Biol 2006; 173:627-37.
38. Bjerre A, Brusletto B, Mollnes TE, et al. Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant. J Infect Dis 2002; 185:220-8.
39. Brandtzaeg P, Bjerre A, Ovstebo R, Brusletto B, Joo GB, Kierulf P. Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 2001; 7:401-20.
40. Dunn KL, Virji M, Moxon ER. Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: The synergistic effect of LPS and pili. Microb Pathog 1995; 18:81-96.
41. Schubert-Unkmeir A, Konrad C, Slanina H, Czapek F, Hebling S, Frosch M. Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: A role for MMP-8. PLoS Pathog 2010; 6:e1000874.
42. Heyderman RS, Klein NJ, Daramola OA, et al. Induction of human endothelial tissue factor expression by Neisseria meningitidis: The influence of bacterial killing and adherence to the endothelium. Microb Pathog 1997; 22:265-74.